Natural killer-cell malignancies: diagnosis and treatment (Q36265596)

13 August 2017

1 reference

title

Natural killer-cell malignancies: diagnosis and treatment (English)

1 reference

13 August 2017

Kwong YL

1

1 reference

13 August 2017

publication date

1 December 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

19

1 reference

13 August 2017

issue

12

1 reference

13 August 2017

page(s)

2186-2194

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

13 August 2017

1 reference

Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Natural killer cell lymphoma/leukemia: pathology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Diagnostic cues for natural killer cell lymphoma: primary nodal presentation and the role of in situ hybridisation for Epstein-Barr virus encoded early small RNA in detecting occult bone marrow involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Clinical stage IE primary lymphoma of the nasal cavity: radiation therapy and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Primary nasal and nasopharyngeal lymphomas: a comparative study of clinical presentation and treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Successful treatment of natural killer (NK) cell leukemia following a long-standing chronic active Epstein-Barr virus (CAEBV) infection with allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Aberrant promoter CpG methylation as a molecular marker for disease monitoring in natural killer cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Elevated serum soluble Fas ligand in natural killer cell proliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Autologous stem cell transplantation for nasal NK/T-cell lymphoma: a progress report on its value

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Successful treatment with Erwinia L-asparaginase for recurrent natural killer/T cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

A 2.6 Mb interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural killer/T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Consistent patterns of allelic loss in natural killer cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Post-transplantation lymphoproliferative disease of natural killer cell lineage: a clinicopathological and molecular analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Clinical and virologic characteristics of chronic active Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Vascular lesion in a patient of chronic active Epstein-Barr virus infection with hypersensitivity to mosquito bites: vasculitis induced by mosquito bite with the infiltration of nonneoplastic Epstein-Barr virus-positive cells and subsequent developm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

WHO-EORTC classification for cutaneous lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Sinonasal NK/T-cell lymphomas in the United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Lethal midline granuloma revisited: nasal T/Natural-killer cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Primary natural killer cell lymphoma of skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Isolated uterine relapse of nasal T/Nk cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

CD56+ NK lymphomas: clinicopathological features and prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Treatment of lethal midline granuloma type nasal T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Primary lymphomas of the nasal cavity and paranasal sinuses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Nasal T-cell/natural killer cell lymphoma: CT and MR imaging features of a new clinicopathologic entity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Specific patterns of gene methylation in natural killer cell lymphomas : p73 is consistently involved

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Fas ligand in human serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Serum levels of the nm23-H1 protein and their clinical implication in extranodal NK/T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

L-Asparaginase-Based Induction Therapy for Advanced Extranodal NK/T-Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma/leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Chromosome aberrations are restricted to the CD56+, CD3- tumour cell population in natural killer cell lymphomas: a combined immunophenotyping and FISH study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

A 38-year history of natural-killer-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

EBV-associated, extranodal NK-cell lymphoma, nasal type of the breast, after heart transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Hypereosinophilia with systemic thrombophlebitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403955

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403955

1 reference

Dimensions Publication ID

13 August 2017

1010474068

0 references

1 reference